AstraZeneca Pharma India Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 2,128.097 million compared to INR 1,982.783 million a year ago. Net income was INR 272.789 million compared to INR 95.786 million a year ago. Basic earnings per share from continuing operations was INR 10.91 compared to INR 3.83 a year ago. For the full year, total revenue was INR 8,264.052 million compared to INR 8,447.97 million a year ago. Net income was INR 933.033 million compared to INR 722.208 million a year ago. Basic earnings per share from continuing operations was INR 37.32 compared to INR 28.89 a year ago.